FDA Emergency Use Authorization Awarded to the Beckman Coulter Access IL-6 Test
Beckman Coulter Diagnostics, Beckman Coulter
The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients